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Abstract
Background: African Americans with Type 2 diabetes (T2DM) have higher prevalence of diabetes, poorer
metabolic control, and greater risk for complications and death compared to American Whites. Poor outcomes in
African Americans with T2DM can be attributed to patient, provider, and health systems level factors. Provider and
health system factors account for <10% of variance in major diabetes outcomes including hemoglobin A1c
(HbA1c), lipid control, and resource use. Key differences appear to be at the patient level. Of the patient level
factors, consistent differences between African Americans and American Whites with T2DM have been found in
diabetes knowledge, self-management skills, empowerment, and perceived control. A variety of interventions to
improve diabetes self-management have been tested including: 1) knowledge interventions; 2) lifestyle
interventions; 3) skills training interventions; and 4) patient activation and empowerment interventions. Most of
these interventions have been tested individually, but rarely have they been tested in combination, especially
among African Americans who have the greatest burden of diabetes related complications. This study provides a
unique opportunity to address this gap in the literature.
Methods/Design: We describe an ongoing four-year randomized clinical trial, using a 2 × 2 factorial design, which
will test the efficacy of separate and combined telephone-delivered, diabetes knowledge/information and
motivation/behavioral skills training interventions in high risk African Americans with poorly controlled T2DM
(HbA1c ≥ 9%). Two-hundred thirty-two (232) male and female African-American participants, 18 years of age or
older and with an HbA1c ≥ 9%, will be randomized into one of four groups for 12-weeks of phone interventions:
(1) an education group, (2) a motivation/skills group, (3) a combined group or (4) a usual care/general health
education group. Participants will be followed for 12-months to ascertain the effect of the interventions on
glycemic control. Our primary hypothesis is that among African Americans with poorly controlled T2DM, patients
randomized to the combined diabetes knowledge/information and motivation/behavioral skills training
intervention will have significantly greater reduction in HbA1c at 12 months of follow-up compared to the usual
care/general health education group.
Discussion: Results from this study will provide important insight into how best to deliver diabetes education and
skills training in ethnic minorities and whether combined knowledge/information and motivation/behavioral skills
training is superior to the usual method of delivering diabetes education for African Americans with poorly
controlled T2DM.
Trial registration: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier# NCT00929838).
* Correspondence: egedel@musc.edu
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Diabetes affects approximately 23.6 million people or
7.8% of the United States population [1]. Diabetes is
associated with significant morbidity, mortality,
increased health care utilization, and increased health
care costs [1]. Diabetes is the leading cause of cardiovas-
cular disease (CVD), strokes, blindness, and lower limb
amputations [2]. It was the seventh leading cause of
death listed on U.S. death certificates in 2006, and indi-
viduals with diabetes have a two-fold increased risk of
death compared to individuals without diabetes of simi-
lar age and sex [1]. Type 2 diabetes accounts for 90-95%
of all cases of diabetes in the United States [1].
African Americans are almost twice as likely to have
diabetes as white Americans of similar age [1]. Approxi-
mately 14.7% of African Americans over age 20 years
have diabetes compared to 9.8% of non-Hispanic Ameri-
can Whites [1]. The prevalence of diabetes in African
Americans has increased dramatically in recent times
[1]. Type 2 diabetes is the most prevalent type of dia-
betes in African Americans accounting for 90 to 95% of
all cases [1]. African Americans have higher incidence
of and greater disability from diabetes complications
than white Americans [1]. African Americans with dia-
betes are four-times more likely to develop ESRD than
their American White counterparts with diabetes [1].
Diabetic retinopathy is 40-50% more frequent in African
Americans than in white Americans [1]. Also, African
Americans with diabetes are much more likely to
undergo a lower-extremity amputation than white or
Hispanic Americans with diabetes [1]. Death rates for
people with diabetes are 20-40 percent higher in African
Americans compared with white Americans [1]. Thus,
evidence indicates that diabetes is a significant public
health problem; and African Americans appear dispro-
portionately burdened with the complications and dis-
ability that result from poorly treated diabetes.
Data from recent studies have shown that Blacks have
poorer glycemic and blood pressure control than Ameri-
can Whites [3-5]. In a nationally representative sample,
[4] after controlling for relevant covariates, African
Americans with diabetes were more likely to have poor
glycemic control and poorly controlled blood pressure.
In a more recent study [5], national trends in processes
of care and intermediate outcomes for diabetes between
1988-1994 and 1999-2002 were compared using national
data. The study showed that although diabetes processes
of care and intermediate outcomes have improved
nationally, 1 in 3 persons still have poor blood pressure
control, and 1 in 5 persons still have poor glycemic con-
trol. Ethnic minority patients (including African Ameri-
cans) had poorer improvements in glycemic and blood
pressure control over the study period.
Several reasons contribute to poor diabetes outcomes
in African Americans. These include factors at the
patient, provider, and health systems levels. Patient level
factors include poor diabetes-specific knowledge, nega-
tive belief and attitudes about diabetes, lack of self-man-
agement skills, and non-adherence to lifestyle behaviors
[6-8]. Other factors include mismatch of patient and
physician expectations, differential socioeconomic levels
that impede physician-patient communication, and dis-
trust of physicians that may decrease adherence [9,10].
Language barriers and low literacy rates also impede
physician-patient communication [10,11]. Other impor-
tant patient level factors include lack of a locus of con-
trol [12] and fatalism [13]. Provider level factors include
negative beliefs and attitudes about diabetes [14], per-
ceived complexity and difficulty of treating diabetes
[15,16], lack of adequate time and resources for diabetes
treatment [16,17] and clinical inertia [18-20]. Health sys-
tems factors include accessibility, availability and conve-
nience of appointments, organization of care, availability
of interpreters, health insurance coverage, reimburse-
ment levels, and formulary restrictions [21].
While provider and health system level factors are
important for improved glycemic control, they explain
<10% of variance in diabetes outcomes including glyce-
mic control, lipid control, and resource use/cost [22,23].
Most of the variation in diabetes outcomes is due to
patient level factors. Of the patient level factors, consis-
tent differences between African Americans and Ameri-
can Whites with T2DM have been found in diabetes
knowledge, self-management skills, empowerment, and
perceived control [6-8,12,13,21].
This paper describes the rationale, study aims and
objectives, and research design and methods of an
ongoing four-year, randomized clinical trial testing the
efficacy of separate and combined telephone-delivered,
diabetes knowledge/information and motivation/beha-
vioral skills training intervention in high risk African
Americans with poorly controlled T2DM (HbA1c ≥ 9%).
The long-term goal of the project is to achieve improve-
ment in diabetes-related outcomes in this patient
population.
Rationale
Despite the compelling evidence of the effectiveness of
diabetes self-management interventions, several limitations
hinder their generalizability to high risk African Ameri-
cans with T2DM. First, few studies recruited sufficient
number of African Americans with T2DM to establish the
effectiveness of these interventions in this patient popula-
tion. Second, there are no randomized clinical trials that
have compared diabetes knowledge/information, motiva-
tion/behavioral skills training, or the combination of both
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prior studies have tested these interventions individually.
Rarely have they been tested in combination or compared
against one another in a randomized clinical trial. Given
the high burden of disease and poorer outcomes in Afri-
can Americans, it is critical to identify effective interven-
tions for this population. Third, internal validity was
frequently threatened by lack of blinding of the assessors,
contamination of the control group, unintended co-inter-
ventions, and deficits in the instruments used to measure
diabetes knowledge, self-care, and dietary habits. These
methodological limitations were noted in the systematic
review of effectiveness of diabetes self-management inter-
vention in T2DM by Norris and colleagues [24]. Fourth,
earlier interventions were of limited dose and intensity,
patients had to address multiple behaviors at the same
time, and patients were typically not given the option to
select the behaviors they wanted to address [24]. Finally,
the behavioral theories on which interventions were based
were not adequately described or documented in most
studies [24]. Accordingly, in this study, we evaluate the
efficacy of a combined telephone-delivered, diabetes
knowledge/information and motivation/behavioral skills
training intervention targeting physical activity, diet, medi-
cation adherence, and self blood glucose monitoring in
improving HbA1c levels in high risk African Americans
with poorly controlled T2DM. In addition, we minimize
the methodological limitations of prior patient-level inter-
ventions by eliminating threats to internal validity, basing
the interventions on established behavioral theory, and
delivering adequate dose and intensity of the interventions
based on findings from our preliminary studies.
Study Aims & Objectives
The primary objective of this study is to test the sepa-
rate and combined efficacy of a telephone-delivered dia-
betes knowledge/information and motivation/behavioral
skills training intervention in improving HbA1c levels in
African Americans with T2DM using a 2 × 2 factorial
design.
Methods/Design
The study is a 4 group randomized controlled trial with
randomization of individual participants, blinded out-
comes assessments at baseline, 3-months, 6-months, and
12-months, and concurrent economic evaluation.
Location and Setting
The study sites for this study include the general inter-
nal medicine, endocrine, family medicine, and commu-
nity care clinics affiliated with the Medical University of
South Carolina in Charleston, SC and the primary care
and endocrine clinics of the Ralph H. Johnson VA Med-
ical Center in Charleston, SC.
Ethics and Trial Registration
The study is funded by grant R01DK081121-01A1 from
the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK). The trial is approved by the
Institutional Review Board (IRB) of the Medical Univer-
sity of South Carolina (HR#18334). The trial is regis-
tered on the United States National Institutes of Health
Clinical Trials Registry (ClinicalTrials.gov identifier#
NCT00929838), available online at: http://clinicaltrials.
gov/ct2/show/NCT00929838.
Trial Population and Recruitment
A total of 232 African Americans with T2DM will be
randomized to one of four groups: 1) telephone-delivered
diabetes knowledge/information; 2) telephone-delivered
motivation/behavioral skills training; 3) combined tele-
phone-delivered diabetes knowledge/information and
motivation/behavioral skills training; and 4) usual care.
We use two complementary approaches to identify
eligible study participants. The first method consists of
systematic identification of African American patients
with T2DM. After obtaining approval for a partial
waiver of HIPAA from our local institutional review
board (IRB) and the Research and Development com-
mittee of the Ralph H. Johnson Medical Center, we
use clinic-billing records over the previous 12-month
period to identify African American participants with
ICD-9 codes consistent with a diagnosis of type 2 dia-
betes. The physicians of eligible patients are notified of
their patients’ potential eligibility and asked permission
to enroll their patients in this study. After consent is
obtained from the physicians, letters of invitation on
clinic letterhead signed by the patient’s physician are
mailed to patients from the study clinics. The letter
provides information about the study, explains the
study requirements, and clarifies that only participants
who meet certain criteria will be eligible to participate
in the study. The letter includes an addressed and
stamped post-card that participants can mail back to
indicate interest or lack of interest in participating in
the study. In addition, the letter provides a telephone
number that interested participants can call to receive
detailed information about the study. In the letter,
participants are also informed that they will receive a
follow-up call in two weeks unless they mail back
the post card or call to decline being contacted. Parti-
cipants who mail back the post card and express inter-
est or call the provided telephone number receive
detailed information about the study. Participants
who agree to participate are asked to provide written
consent and are scheduled for the initial screening
assessment.
The second method consists of referrals from physi-
cians, other clinic staff such as nurses, or patients
Egede et al. Trials 2010, 11:35
http://www.trialsjournal.com/content/11/1/35
Page 3 of 11themselves in response to recruitment flyers for the
study. The PI shares the goals of the study and inclu-
sion/exclusion criteria with physicians and clinic staff
during clinic administrative meetings. Physicians and
clinic staff are asked to refer appropriate participants to
the study research assistants. In addition, IRB approved
recruitment flyers are posted in prominent locations in
the study clinics.
Regardless of recruitment pathway, research staffs
obtain written informed consent, complete screening for
eligibility, and assure that participants meet criteria for
inclusion and participation in the study. The procedure
and risks are explained to the patients and the consent
form signed as per standard clinical practice. Partici-
pants who meet eligibility criteria then complete the
remainder of the assessmen tb a t t e r y( s e eT a b l e s1 ,2
and 3).
Randomization
All participants are randomly assigned to one of the
four study arms (n = 58 per arm). Randomization takes
place in waves. Approximately 58 participants are ran-
domized every 6 months. The randomization sequence
is generated by a web-based computer generated rando-
mization scheme. After determining eligibility, enrolled
patients are assigned to treatment groups by the health
educators. The health educators log into the web-based
program and determine which of the 4 groups they are
randomized to. This information is confidential and not
shared with the study investigators in accordance with
the CONSORT guidelines [25]. Once a randomization
assignment is provided, the patient is entered into the
study and is included in the intention to treat analysis.
Intervention and Control Groups
There are three active treatment groups (telephone-
delivered diabetes knowledge/information, telephone-
delivered motivation/behavioral skills training, combined
telephone-delivered diabetes knowledge/information and
telephone-delivered motivation/behavioral skills training)
and a usual care/health education group.
The patient-level intervention is based on the informa-
tion-motivation-behavioral skills model and provides
information, motivation, and behavioral skills training.
Study assessments are performed by a blinded research
assistant at baseline, 3, 6, and 12 months of follow-up.
The primary outcome is HbA1c level at 12 months of
follow-up.
Contents of Individual Treatment Sessions by Intervention
Group
Session 1
After enrollment, randomization, and completing the
baseline assessment, each participant comes in for a
face-to-face meeting with the study health educators
regardless of the group randomized to. During this visit,
the health educators goes over the study in detail,
obtains patient contact information, primary and alter-
nate telephone numbers, and establishes guidelines for
follow-up calls. In addition, participants receive informa-
tion specific to their group as described below:
a. Education group Participants randomized to this
group receive a culturally tailored education booklet
that was developed as part of REACH 2010 titled “Your
Guide to Sugar Diabetes”. This 48 page document is
written in lay language (6
th grade education) for African
Americans with diabetes. Participants are encouraged to
review the materials and discuss questions during subse-
quent diabetes education telephone calls.
The diabetes knowledge/information intervention for
the participants randomized to this group consists of
weekly telephone-delivered diabetes knowledge/informa-
tion lasting 30 minutes for 12 weeks based on American
Diabetes Association (ADA) guidelines. After initially
meeting for session 1, all subsequent sessions (2-13) are
delivered via telephone by the health educators. Partici-
pants randomized to this group participate in discus-
sions on diabetes-related topics, including an overview
of diabetes, self-blood glucose monitoring, medication
adherence, the basics of eating, meal planning, carbohy-
drate counting, exercise, blood pressure, cholesterol,
foot and skin care, and controlling stress levels. At the
completion of session 13, the health educators conduct
a review session, highlighting and summarizing the
major points from the previous sessions.
b. Behavioral skills training intervention group Parti-
cipants randomized to this group are trained on how to
use the 5 patient activation questions during clinic visits.
They are given the patient empowerment package ("Dia-
betes Care Kit”) and trained on how to use the materials
in the diabetes care package. In addition, the health edu-
cator goes over the principles of behavioral skills train-
ing, asks the patient to choose the first target behavior,
and assists the subject in developing an action plan.
The motivation/behavioral skills intervention consists
of patient activation (list of 5 questions to ask their pro-
vider at every visit and training on how to ask the ques-
tions), patient empowerment (diabetes responsibility
contracts and flow charts for patients to record lab
results/medications and training on how to use the flow
charts), and behavioral skills training delivered via tele-
phone lasting 30 minutes every week for 12 weeks. Four
topics-self-blood sugar monitoring, medication adher-
ence, diet, and physical activity-are stressed in these ses-
sions (2-13). Participants randomized to this group have
the option to select the order in which these topics
are discussed. During these sessions, the importance of
the selected behavior in diabetes management, as well as
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maintaining this behavior are assessed by the health
educator. The health educator asks about the partici-
pants’ current status and practices of the behavior, in
addition to any barriers and limitations they face in con-
trolling that particular behavior. At the end of each ses-
sion, the participants have to set a goal to practice over
the next week. During the next session, the health edu-
cator checks the participant’sp r o g r e s so ft h a tg o a la n d
his/her confidence in maintaining that behavior.
c. Combined intervention group Participants rando-
mized to this group receive the culturally tailored educa-
tion booklet that was developed as part of REACH 2010
titled “Your Guide to Sugar Diabetes”. They are trained
on how to use the 5 patient activation questions during
clinic visits. They are also given the patient empower-
ment package and trained on how to use the materials
in the diabetes care package. In addition, the health edu-
cator goes over the principles of behavioral skills train-
ing, asks the subject to chose the first target behavior,
and assists the subject in developing an action plan.
The combined intervention group receives weekly tel-
ephone-delivered diabetes knowledge/information,
patient activation, patient empowerment, and behavioral
skills training delivered via telephone. Telephone ses-
sions (2-13) for the combined intervention group are
delivered weekly for 12 weeks and last for 30 minutes.
Participants randomized to this group participate in
Table 1 Data Collection Schedule
Questionnaires/Measurements Baseline Visit 3-month Visit 6-month visit 12-month visit
Primary Outcome Measure
HbA1c X X X X
Fasting lipid profile X X X X
Secondary Outcome Measures
Physical Activity X X X X
Diet X X X X
Medication Adherence (eCaps) X X X X
Self-Monitoring of Blood Glucose X X X
Blood Pressure X X X X
Resource Use/Cost X X X X
Body Composition (BOD POD) X X
Other Laboratory measurements X X
Anthropometric measurements X X X X
Process Measures
Diabetes Knowledge Questionnaire X X X X
Diabetes Empowerment Scale X X X X
Summary of Diabetes Self-Care Activities Scale X X X X
Treatment Credibility X X
Perceived Diabetes Self Efficacy Scale X X X X
Self-report Measures
Patient Demographics X
Quality of life (SF-12) X X
Social support X X
Health Literacy X X
Depression (PHQ-9) X X X X
Medical Comorbidity (Charlson Index) X X
Morisky Medication Adherence Scale X X X X
Diabetes Fatalism Scale X X X X
Service Delivery Perceptions X X
Assessment of eCaps Use X X X
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Outcome Test Measurement
Primary Outcome
Measures
HbA1c/Fasting Lipid
Profile
Blood specimens will be obtained at baseline, 3-, 6- and 12-months visits.
Secondary Outcome
Measures
Laboratory
Measurements
Blood specimens will be obtained at baseline and 12-months visits.
Physical Activity The seven-day physical activity recall (PAR) will be used to measure of physical activity [29,30].
Diet Dietary intake will be assessed using the Block 1998 Food Frequency Questionnaire [31-36].
Medication Adherence The eCAP® electronic compliance monitor (Information Mediary Corporation, Ottawa, Canada) will
serve as the primary measure of medication adherence for this study.
Self-monitoring of
Blood Glucose
Glucometer downloads will be used to assess self-monitoring adherence.
Blood pressure
measurements
Blood pressure readings will be obtained at baseline, 3-, 6- and 12-months by a trained RA using
automated BP monitors (OMRON IntelliSense™ HEM-907XL) with the patient seated comfortably for 5
minutes prior to the measurements.
Resource Utilization &
Cost
The perspective of cost will be that of the payer. Previously validated questions on resource
utilization will be administered as part of the baseline, 3-, 6-, and 12-month assessments.
Body Composition The BOD POD Gold Standard (Life Measurement, Inc., Concord, CA) will serve as the primary measure
of body composition for this study.
Anthropometrics Measurements of body fat including height, weight, BMI, waist circumference, waist-to-hip ratio, and
skinfold thickness will be obtained at baseline, 3-, 6-, and 12-month visits.
Table 3 Data Collection Instruments
Measure Data Collected Method
Process
Measures
Information This will be measured by the 24-item Diabetes Knowledge Questionnaire (DKQ) [37].
Motivation This will be measured by the 8-item Diabetes Empowerment Scale-Short Form (DES-SF) [38].
Self-Efficacy This will be measured by the perceived diabetes self-management scale (PDSMS) [39].
Behavioral Skills This will be assessed with the Summary of Diabetes Self-Care Activities (SDSCA) scale [40].
Treatment Credibility To assess for differences in outcome expectancy, a modified treatment credibility scale developed by
Borkovec and Nau (1972) will be used [41].
Self-report
measures
Demographics Previously validated items from the 2002 National Health Interview Survey [42] will be used to capture
age, gender, race/ethnicity, marital status, household income, and health insurance.
Quality of Life Quality of life will be measured by the SF-12 [43], which is a valid and reliable instrument to measure
functional status.
Social support The Medical Outcomes Study (MOS) Social Support Survey [44] will be used to measure social support.
Health Literacy The abbreviated version of the Test of Functional Health Literacy in Adults (S-TOFHLA) [45] is designed
to rapidly screen patients for potential health literacy problems.
Depression The PHQ-9 is a brief questionnaire that scores each of the 9 DSM-IV criteria for depression [46].
Medical Comorbidity The patient’s history of medical comorbidity will be documented using a standardized and validated
questionnaire(ref#200) [42].
Self-Reported Medication
Adherence
This will be measured with the new 8-item self-report Morisky Medication Adherence Scale (MMAS) [47].
Diabetes Fatalism This will be measured with the 12-item Diabetes Fatalism Scales (DFS) [48].
Service Delivery
Perceptions
This will be assessed with 5 items that have been previously validated in mental health studies. The
items were slightly modified to be relevant to diabetes.
Assessment of ECAPS
Use
A brief 8-item scale will be used to assess the ease of use of the electronic medication adherence pill
bottle.
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vation/skills training in self-blood sugar monitoring,
medication adherence, diet, and physical activity, as out-
lined in the education group and the behavioral skills
training group above. During the final week of discus-
sion, a review of the major points of each session cov-
ered previously will be conducted.
d. Usual care group Participants randomized to this
group receive general health information booklets. The
men receive a 23-page booklet titled “What I Need to
Know about Prostate Problems”,w h i l et h ew o m e n
receive a 19-page booklet titled “What I Need to Know
about Urinary Tract Infections”. Both booklets are writ-
ten in lay language. Participants are encouraged to
review the materials and discuss questions during subse-
quent education telephone calls.
The usual care group receives weekly telephone-deliv-
ered general health education (sessions 2-13) lasting 30
minutes every week for 12 weeks to control for atten-
tion. Participants randomized to this group discuss gen-
eral health education topics which include managing
back pain, sleep problems, stroke and transient ischemic
attacks (TIAs), vitamins, health care insurance, hepatitis
viruses, influenza and pneumonia, dyspepsia, colon can-
cer, migraine headaches, sore throat, and esophageal
reflux (GERD).
At the completion of session 13, regardless of the
assigned group, all participants are congratulated on
their success and scheduled for a 3-month follow-up
appointment.
Several intervention materials used in the study are
copyrighted and cannot be made publicly available with-
out the consent of the copyright owners. However, man-
uals developed as part of this study will be shared in a
timely fashion with researchers in both the private and
public sector for a nominal charge and with minimal
restriction in accordance with United States National
Institute of Health and our institutional guidelines.
Study Instruments and Data Collection Schedule
See Figure 1 and Tables 1, 2 and 3, for the study design
and study flow, data collection schedule, data collection
measures, and data collection instruments, respectively.
Intervention Delivery, Treatment Integrity, and Treatment
Adherence
Two full-time masters-level trained health educators
(HE) deliver the interventions. Each HE provides care to
the participants in all of the four study groups.
Training and supervision of interventionists (health
educators)
Training in the basic elements of behavioral skills train-
ing and ongoing supervision and oversight of the coach-
ing sessions is provided by the study consultant
(psychologist). Training consists of two full days of
information and role-playing in behavioral skills training
in year 01 and then two day booster sessions in years 2-
4 to minimize drift in counseling skills. The Principal
Investigator (PI) trains the health educators on content
and conduct of diabetes and general health education
sessions. The initial training involves role plays, and
basic skills in running of telephone sessions. Additional
training on the behavioral framework on which the
intervention is based is also provided.
Treatment fidelity checks
In order to ensure that treatments are competently
administered in accordance with the study protocol, all
sessions are audiotaped, and 20% of these are randomly
selected and rated for competence and adherence by
co-investigators. This allows assessment for group dif-
ferences on non-specific factors, such as interventionist
empathy and rapport. To evaluate interventionist adher-
ence, rating forms were developed based upon the treat-
ment protocol to determine if the health educators
appropriately covered the content of each session
(i.e., demonstrated the particular behavior described in
each item). To evaluate competence, rating forms were
developed to assess how well the health educators
accomplish a range of relevant tasks for each session
(i.e., how well they carried out the particular behaviors
described in each item). These rating forms use Likert
scale response formats, and are modeled after the treat-
ment fidelity forms used in other studies by the PI and
members of the team. Review and rating of a random
sample of audiotapes is used to assess for fidelity to
treatment.
Patient compliance with treatment protocol
This is a very important aspect of the study given the
intensity of the intervention protocol. We adopted the
following strategies to ensure an optimal level of com-
pliance: (1) at enrollment the health educators stress the
importance of attending the sessions; (2) the health edu-
cators place reminder telephone calls to participants on
the day or evening prior to each session; (3) the health
educators request the names and telephone numbers of
three of the participant’s friends and/or relatives who
know how to reach the participant in the event the
team is unable to reach them; (4) the research staff are
flexible in accommodating participants’ schedules, so the
telephone sessions can be conducted at times conveni-
ent for the participant; (5) participants receive a wel-
come package at enrollment and cards on birthdays or
significant life events. In addition, participants are sent
newsletters with useful information and testimonials
from other study participants every 6 months to
improve retention. Finally, participants are reimbursed
$25 for the baseline, 3-, 6-, and 12-month follow-up vis-
its for a total of $100 over the study duration.
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The 4 behaviors that are the target of this intervention
are physical activity, diet, medication adherence, and
glucose self-monitoring. Changes in these behaviors are
being assessed as measures of treatment enactment.
Primary Outcome Measure
The primary outcome is HbA1c level at 12 months of
follow-up.
Sample Size Determination and Power Analysis
T h es a m p l es i z ec a l c u l a t i o n sa r eb a s e do nt e s t i n gt h e
three hypotheses in the 2 × 2 factorial design: 1) the
overall effect of diabetes knowledge/information versus
no diabetes knowledge/information, 2) the overall effect
of motivation/behavioral skills versus no motivation/
behavioral skills, and 3) the effect of the combined inter-
ventions. The primary endpoint for testing these
hypotheses is the 12 month HbA1c value. The clinically
relevant difference in HbA1c at 12 months is 1-percen-
tage point and is based upon the findings of a previous
RCT of telephone-delivered diabetes intervention [26]
and our pilot study. In the study by Piette and collea-
gues [26], they found that after 12 months, the tele-
phone intervention group lowered HbA1c by 1.1% when
the baseline HbA1c was ≥ 9%. In our pilot study, we
found that after 6 months, the telephone intervention
group lowered HbA1c by 0.95% (sd 1.2), while the con-
trol group increased HbA1c by 0.3% (sd 1.5) (p = 0.06).
Sample size estimation is based on a 2 × 2 factorial
design and takes into account the potential interaction
between the diabetes knowledge/information and moti-
vation/behavioral skills intervention. Although the com-
mon advantage of a 2 × 2 factorial design is the
c o n s e r v a t i o no fs a m p l es i z ei nt h ea b s e n c eo fi n t e r a c -
tion, the alternative advantage is a gain in information
on the interaction between two interventions. A total of
42 participants per arm is required to achieve 85%
power (type I error rate of 0.05) to detect a clinically
relevant difference of 1 percentage point in the 12-
month HbA1c (assuming a common standard deviation
of 1.5). Because testing for an interaction can greatly
increase the sample size and since interaction is not our
specific interest, we chose to ensure that we have ade-
quate power to detect main effects in the presence of an
interaction. Thus the total number of participants
required for randomization is 168 participants (42 per
treatment arm). The total sample size is inflated by a
factor of 1.38 to account for an anticipated 15% attrition
rate in an intent-to-treat analysis [27]. Thus a total of
232 participants will be randomized into this study. In
the absence of interaction, the test comparing tele-
phone-delivered diabetes knowledge/information versus
usual care has greater than 95% power at a significance
level of 0.025 to detect a difference of 1 percentage
point. The test comparing telephone-delivered motiva-
tion/behavioral skills training versus usual care has the
same power to detect a similar difference.
Data Analysis
Primary Hypotheses
Among African Americans with poorly controlled
T2DM, patients randomized to the telephone-delivered
diabetes knowledge/information intervention, the tele-
phone-delivered motivation/behavioral skills training
intervention or the combined intervention will have sig-
nificantly greater reduction in HbA1c at 12 months of
follow-up compared to usual care.
The primary framework for analysis is analysis of cov-
ariance. Twelve-month HbA1c measurements (depen-
dent variable) will be compared between treatment arms
using a model-based approach with telephone-delivered
diabetes knowledge/information, telephone-delivered
motivation/behavioral skills training and the interaction
of the two factors in the model along with baseline
HbA1c as a covariate. A global test approach will
be implemented in order to preserve the type I error
rate [28]. The first test to be conducted is an overall test
of differences among the four treatment arms using a
type I error rate of 0.05. If the test on the null hypoth-
esis of all four arms being equal is not significant then
we will conclude that usual care is the treatment of
choice with no further testing. If the test is significant
then we will proceed with a test for interaction at the
0.10 significance level. If the interaction is not signifi-
cant and either of the main treatment effects is signifi-
cant, we will examine the effect on HbA1c in those
participants assigned to the respective treatment versus
those not assigned. If the interaction test is significant
and favorable, usual care versus telephone-delivered dia-
betes knowledge/information and usual care versus tele-
phone-delivered motivation/behavioral skills training
will be tested. If both are significant, the combination of
the two will be considered the best treatment. If only
one is significant, then a test of the one intervention
versus the combination will be conducted, and if neither
are significant than the combination will be compared
against usual care. There is no clinical/scientific reason
to expect an unfavorable interaction; however, if one is
detected the comparison of treatments to usual care will
be conducted to determine which treatment is superior.
All primary comparison tests will be conducted at the
0.05 significance level.
A mixed model repeated meas u r e sa n a l y s i so fc o v a r -
iance will be conducted as a secondary analysis to assess
the difference in HbA1c levels over time. The model will
include telephone-delivered diabetes knowledge/informa-
tion and telephone-delivered motivation/behavioral skills
Egede et al. Trials 2010, 11:35
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Page 9 of 11training and the interaction of the two as factors in the
model along with baseline HbA1c as a covariate. A simi-
lar analysis plan using a global test approach as describe
above will be implemented. If the interaction is not sig-
nificant, it will be dropped from the model. Covariance
structures will be assessed during the model-fitting
process.
Discussion
The study was funded in August 2008. Study recruit-
ment began in May 2009, with all follow-up assessments
associated with the study expected to be completed by
June 2012. As of March 24 2010, 176 have been sched-
uled, 104 enrolled, and 95 randomized. Of the number
randomized, 61 have completed the 12-week phone
interventions, and 52 have completed the 3-month fol-
low-up assessment and 33 have completed the 6-months
follow-up assessment.
The proposed study provides a unique opportunity to
address existing gaps in the literature by testing a com-
bined telephone-delivered, diabetes knowledge/informa-
tion and motivation/behavioral skills training
intervention in African Americans with poorly con-
trolled T2DM. The combined diabetes knowledge/infor-
mation and motivation/behavioral skills intervention
focuses on four key behaviors (physical activity, diet,
medication adherence, and self-monitoring of blood glu-
cose); maintain adequate dose and intensity of the inter-
ventions by delivering the interventions weekly for 12
weeks; and allow patients to choose one behavior to
address every 3 weeks. The findings of this study, if suc-
cessful, will lead to the implementation of this feasible,
evidence-based intervention for high risk minority
patients with T2DM. The study will provide new infor-
mation on how to improve quality of care for diabetes
in ethnic minorities and reduce the disproportionate
burden of diabetes complications and deaths in ethnic
minority groups with T2DM.
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